Value of Diagnostics within Women’s Health: Lung Cancer
Lung cancer is the second most common non-skin cancer in women, and the leading cause of cancer death in the United States – for both women and men. One in 17 women will develop lung cancer in her lifetime. For women who smoke, this risk increases.
Innovations in diagnostics provide access to health information and can help women make informed decisions about their lung health and care.
In recognition of World Lung Cancer Day on August 1, the Society for Women’s Health Research (SWHR) published the Value of Diagnostics within Women’s Health: Lung Cancer Fact Sheet to highlight the impact of lung cancer on women’s health and share information about the role of lung health screenings and tests – like an imaging test, cytology test, and bronchoscopy – on health across the lifespan.
DOWNLOAD THE LUNG CANCER FACT SHEET
This fact sheet is part of the Value of Diagnostics within Women’s Health Series, created to share educational information about the value of innovative diagnostics across disease states and conditions. This year’s series focuses on cancer and healthy aging.
Lung cancer is the second most common non-skin cancer in women, and the leading cause of cancer death in the United States – for both women and men. One in 17 women will develop lung cancer in her lifetime. For women who smoke, this risk increases.
Innovations in diagnostics provide access to health information and can help women make informed decisions about their lung health and care.
In recognition of World Lung Cancer Day on August 1, the Society for Women’s Health Research (SWHR) published the Value of Diagnostics within Women’s Health: Lung Cancer Fact Sheet to highlight the impact of lung cancer on women’s health and share information about the role of lung health screenings and tests – like an imaging test, cytology test, and bronchoscopy – on health across the lifespan.
DOWNLOAD THE LUNG CANCER FACT SHEET
This fact sheet is part of the Value of Diagnostics within Women’s Health Series, created to share educational information about the value of innovative diagnostics across disease states and conditions. This year’s series focuses on cancer and healthy aging.
Webinar highlights from the Value of Diagnostics within Women’s Health Series:
2022 Series
- How Vaccines and Screening Can Prevent Cervical Cancer
- Improving Lives by Detecting Sexually Transmitted Infections Early
- Assessing and Promoting Bone Health Across the Lifespan
- How Hormones Can Tell a Fertility Story
- Ovarian Cancer Screening: More than a Pelvic Exam
- Understanding the Tests that Could Save My Breasts
2023 Series
- Taking it to Heart: Addressing Cardiovascular Disease in Women
- Putting our Heads Together: Diagnostic Innovations for Alzheimer’s Disease
- Clearing the Air About Lung Cancer in Women
SWHR’s Value of Diagnostics within Women’s Health series is supported by an educational sponsorship from Roche. SWHR maintains independence and editorial control over program development, content, and work products.
This material was created by the Society for Women’s Health Research (SWHR) and is intended to serve as a public educational and informative resource. This material may be cited or shared on external channels, websites, and blogs, with attribution given to SWHR, or printed and displayed in its original formatted version. SWHR encourages the sharing and reposting of its content in order to spread awareness around women’s health issues. For specific questions about sharing SWHR content, please reach out to communications@swhr.org.